Aripiprazole and Hyperlactacidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlactacidaemia is reported as a side effect among people who take Aripiprazole (aripiprazole), especially for people who are female, 60+ old, also take Amisulpride, and have Mental disorder.

The phase IV clinical study analyzes which people have Hyperlactacidaemia when taking Aripiprazole. It is created by eHealthMe based on reports of 38,853 people who have side effects when taking Aripiprazole from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Hyperlactacidaemia?

Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney) is found to be associated with 239 drugs and 272 conditions by eHealthMe. Check the latest studies of Hyperlactacidaemia.

On Jul, 07, 2026

38,853 people reported to have side effects when taking Aripiprazole.
Among them, 11 people (0.03%) have Hyperlactacidaemia.

Could Aripiprazole cause Hyperlactacidaemia?

Among these 11 people:

What is the gender of people who have Hyperlactacidaemia when taking Aripiprazole? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperlactacidaemia when taking Aripiprazole? *

What are other drugs people take besides Aripiprazole? *

Amisulpride: 11 people, 100.00%

What are other side effects people have besides Hyperlactacidaemia? *

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 11 people, 100.00%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 11 people, 100.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 11 people, 100.00%
Loss Of Consciousness: 10 people, 90.91%
Haemodynamic Instability (disturbances in the blood movement in our body): 10 people, 90.91%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 10 people, 90.91%
Drug Ineffective: 9 people, 81.82%
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 6 people, 54.55%
Mydriasis (a dilation of the pupil): 6 people, 54.55%
Hyperhidrosis (abnormally increased sweating): 6 people, 54.55%

What are the existing conditions these people have? *

Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 10 people, 90.91%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and have Hyperlactacidaemia?

- Check whether Hyperlactacidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aripiprazole:

Aripiprazole (39,143 reports)

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlactacidaemia:

Hyperlactacidaemia (239 drugs)

Browse all the conditions that are associated with Hyperlactacidaemia:

Hyperlactacidaemia (272 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Aripiprazole) and Aripiprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.